Acute leukemia after alkylating-agent therapy of ovarian cancer.

To estimate the leukemogenic potential of alkylating agents, we surveyed 70 institutions using these drugs for the frequency of second cancers in patients with advanced ovarian cancer. Thirteen cases of acute nonlymphocytic leukemia occurred among 5455 patients, as compared to 0.62 cases expected (relative risk = 21.0). All 13 had received alkylating agents. Nine also received radiotherapy. The relative risk for patients given chemotherapy was 36.1 and rose to 171.4 for those surviving for two years (rate = 13.75 per 1000 patients per year). To evaluate the role of therapy versus underlying disease, a historical control of 13,309 patients with ovarian cancer in the National Cancer Institute's End Results Program was analyzed. No excess of leukemia was noted in this group, even among 6596 women receiving radiation. The excess of acute nonlymphocytic leukemia, therefore, appears attribute to alkylating agents, although the effect may be enhanced by exposure to radiation, as previously suggested for Hodgkin's disease.

[1]  H. Latourette,et al.  A national cooperative program for the evaluation of end results in cancer. , 1959, Journal of the National Cancer Institute.

[2]  J. Bailar,et al.  Radiation therapy for cervical cancer: Late effects on life span and on leukemia incidence , 1971, Cancer.

[3]  J. Wharton,et al.  CHEMOTHERAPY OF OVARIAN CANCER , 2006 .

[4]  F. Rosner,et al.  Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature. , 1974, The American journal of medicine.

[5]  M. Bauchinger,et al.  Chromosome analysis in mammalian cells after exposure to lead in vitro and in vivo , 1973 .

[6]  R. Hoover,et al.  Risk of cancer in renal-transplant recipients. , 1973, Lancet.

[7]  B. Ruffner.  Letter: Androgen role in erythroleukemia after treatment with alkylating agents. , 1974, Annals of Internal Medicine.

[8]  G. Hutchison.  Leukemia in patients with cancer of the cervix uteri treated with radiation. A report covering the first 5 years of an international study. , 1968, Journal of the National Cancer Institute.

[9]  Roberts Mm.  Acute leukaemia after immunosuppressive therapy. , 1976 .

[10]  L. Delclos,et al.  Management of ovarian carcinoma, Surgery, irradiation, and chemotherapy. , 1967, American Journal of Obstetrics and Gynecology.

[11]  J. Whang‐Peng,et al.  SECOND MALIGNANCIES COMPLICATING HODGKIN'S DISEASE IN REMISSION , 1975, The Lancet.

[12]  E. Greenspan,et al.  Acute myeloblastic leukemia after cure of ovarian cancer. , 1974, JAMA.

[13]  C. Shellabarger.  Effect of 3-methylcholanthrene and x- irradiation, given singly or combined, on rat mammary carcinogenesis. , 1967, Journal of the National Cancer Institute.

[14]  W. Allan.  Acute myeloid leukaemia after treatment with cytostatic agents. , 1970, The Lancet.

[15]  R. Greenberg,et al.  Occurrence of Certain Multiple Primary Cancers in Females , 1969 .

[16]  A. Cappellini,et al.  Chromosome changes and their evolution in subjects with past exposure to benzene. , 1971, Archives of environmental health.

[17]  H. Vogel,et al.  Cocarcinogenesis: the interaction of chemical and physical agents. , 1971, Radiation research.

[18]  F. Rosner.  Acute leukemia as a delayed consequence of cancer chemotherapy , 1976, Cancer.

[19]  D. Garfield.  Acute erythromegakaryocytic leukaemia after treatment with cytostatic agents. , 1970, The Lancet.

[20]  M. Perlman,et al.  Acute leukemia following cytotoxic chemotherapy. , 1973, Journal of the American Medical Association (JAMA).

[21]  C. Smit,et al.  Acute myeloid leukaemia after treatment with cytostatic agents. , 1970, Lancet.

[22]  R. Kyle,et al.  Multiple myeloma and acute myelomonocytic leukemia. , 1970, The New England journal of medicine.

[23]  P. McKenna,et al.  Acute leukemia complicating metastatic breast cancer , 1973, Cancer.

[24]  U. Ehling.  Comparison of radiation-and chemically-induced dominant lethal mutations in male mice. , 1971, Mutation research.

[25]  T. Schroeder,et al.  Spontaneous chromosomal breakage and high incidence of leukemia in inherited disease. , 1971, Blood.

[26]  V. Devita,et al.  Perspectives on research in gynecologic oncology. Treatment protocols , 1976 .

[27]  C. C. Harris,et al.  Immunosuppressive anticancer drugs in man: their oncogenic potential. , 1975, Radiology.

[28]  D. Schottenfeld,et al.  Incidence of Multiple Primary Cancers. IV. Cancers of the Female Breast and Genital Organs , 1971 .